Rep. Jared Moskowitz (D-FL) Sells Cencora (COR) Stock
Jared Moskowitz, a Democratic member of the House from Florida, sold shares of Cencora, Inc. on May 6, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Rep. Jared Moskowitz (D-FL) sold between $1,001 and $15,000 of Cencora, Inc. ($COR) stock on May 6, 2026. The trade was disclosed in a STOCK Act periodic transaction report filed June 19, 2026.
Since the trade, $COR is up 1.2% after 1 week, up 9.1% after 1 month and up 35.5% to date (from the $251.67 close on May 6, 2026).
Financial Disclosure Report
Clerk of the House of Representatives • Legislative Resource Center • B81 Cannon Building • Washington, DC 20515
Filer Information
- Name:
- Rep. Jared Moskowitz (D-FL)
- Status:
- Member — House
- State/District:
- FL-23
- Party:
- Democrat
Filing Information
- Filing Type:
- Periodic Transaction Report
- Filing Year:
- 2026
- Filing Date:
- Jun 19, 2026
Schedule B: Transactions
| Asset | Transaction | Date | Amount |
|---|---|---|---|
| Cencora, Inc. ($COR) | Sell | May 6, 2026 | $1,001 - $15,000 |
Summary of the filed report, not the original document. Find the original: House financial disclosure search
COR
Cencora, Inc.
Key Points
- Jared Moskowitz sold shares of Cencora, Inc. valued between $1,001 and $15,000 on May 6, 2026.
- Cencora, Inc. reported revenue of $332.8 billion for the last year, highlighting its significant role in healthcare distribution.
- Analysts maintain a consensus rating of 'buy' for Cencora, with a target mean price of $369.31.
Get $COR trade alerts by text
We text you when insiders, Congress or big funds trade $COR. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Cencora, Inc. alert may contain errors. Disclosures
Moskowitz's Recent Sale
On May 6, 2026, Jared Moskowitz, a Democratic House member from Florida, sold shares of Cencora, Inc. (NYSE: COR) valued between $1,001 and $15,000. This transaction was reported on June 19, 2026, as part of the required disclosures for congressional stock trades.
Jared Moskowitz vs. the S&P 500
Hypothetical returns from Jared Moskowitz's disclosed trades, not real profit or advice. How we model this.
Why This Matters
Moskowitz's sale comes as Cencora continues to play an important role in the healthcare sector, focusing on the distribution of pharmaceutical products. The company has a substantial market cap of approximately $60.4 billion and reported revenue of $332.8 billion in its latest fiscal year. This sale may reflect Moskowitz's personal financial strategy, but it also occurs in a context of significant corporate activity in the medical distribution industry.
Analysts Set New Price Targets
Analysts have a generally positive view of Cencora, Inc. On October 16, 2026, UBS maintained a 'Buy' rating with a price target of $400, down from a previous target of $430. Similarly, Leerink Partners reiterated an 'Outperform' rating with a target of $388 on October 7, 2026. RBC Capital has a 'Sector Perform' rating with a target of $330, unchanged since August 19, 2026. The consensus among 13 analysts suggests a mean price target of $369.31, indicating confidence in the company's future.
Insider Buying and Selling at Cencora, Inc.
On June 18, 2026, Dermot Mark, an insider at Cencora, bought 4,000 shares at an average price of $274.19, totaling approximately $1.1 million. This purchase indicates ongoing insider confidence in the company's stock performance, contrasting with Moskowitz's recent sale.
What Cencora, Inc. Does
Cencora, Inc., formerly known as AmerisourceBergen Corporation, is headquartered in Conshohocken, Pennsylvania. The company specializes in sourcing and distributing pharmaceutical products across the U.S. and internationally, serving various healthcare providers. Its operations are crucial to ensuring healthcare access and efficiency, which is particularly relevant to Moskowitz's district and his work in Congress.
What's Next for Cencora, Inc.
Investors will be watching for Cencora's next earnings report scheduled for November 4, 2026. This upcoming report will provide insights into the company's financial health and performance trends. As a reminder, the recent sale by Moskowitz reflects his past position and may not represent his current holdings in Cencora, Inc.
Related Filing Alerts
Source: Jared Moskowitz's STOCK Act disclosure on $COR (May 6, 2026). Find the original filing: House financial disclosure search. Written by software, not financial advice. How we make alerts